ROLE SUMMARY
Sustainable growth in the Middle East depends on the price every market pays and the evidence every payer accepts. The Senior Manager, Pricing, HTA & HEOR leads the Middle East centre of excellence for pricing, international reference pricing, health-technology assessment and health-economics evidence, and chairs the regional pricing governance forum. The role sets a consistent pricing approach across Middle East markets, owns the launch readiness gate that confirms price, evidence and access readiness for every asset before submission, and leads the HEOR and value-evidence agenda through the HEOR Manager Middle East.
Based in Cairo, the role is the subject-matter authority on the Egyptian Drug Authority pricing and repricing framework, Gulf external reference pricing and harmonization, Levant and Iraq registration-linked pricing, and tender pricing. It leads a team of three, sets the standards applied across the region, and is a member of the Middle East Access & Value leadership team.
CORE ACCOUNTABILITIES
1. PRICING AND REFERENCE STRATEGY
•Develop and maintain the Middle East regional pricing approach, launch-price architecture and lifecycle pricing for new and in-market assets, aligned with enterprise pricing principles.
•Set launch sequencing across markets to protect international reference prices and GCC harmonization exposure; model cross-market interdependencies and recommend mitigations.
•Lead Egypt pre-pricing and repricing activities under the applicable Egyptian Drug Authority framework, and the pricing components of reliance and fast-track registrations; oversee Levant and Iraq price-approval strategy through the Pricing Manager Egypt, Levant & Iraq.
•Set tender pricing and discount guardrails for execution by the commercial and tender teams.
2. PRICING GOVERNANCE
•Run regional pricing governance: pricing assumptions, approvals, renewals, exceptions, discounts, rebates and free-goods proposals, with complete and traceable records.
•Embed pricing assumptions and access risk scenarios into business plans, forecasts and launch business cases.
•Escalate material cross-market exposure and policy changes to the Access & Value Lead and regional decision forums with decision-ready options.
3. HTA, HEOR AND VALUE EVIDENCE
•Set the regional HEOR and value-evidence plan: economic models, budget-impact analyses, real-world evidence and value dossiers prioritized by launch, reimbursement and policy needs.
•Lead, through the HEOR Manager Middle East, the local adaptation and quality review of global models and dossiers for Egypt, the Gulf and distributor markets, addressing the needs of health authorities, payers, insurers and tender bodies.
•Partner with Medical and global HEOR to close evidence gaps and bring real-world evidence into access decisions.
4. LAUNCH GATE AND EARLY ACCESS
•Own the launch readiness gate for the launch pipeline: confirm pricing, evidence package, early-access pathway and submission sequence for every asset before filing.
•Design managed-entry and early-access options (pre-pricing, reliance, named-patient, outcome-based agreements) with market access colleagues and Legal/Compliance.
5. PEOPLE, CAPABILITY AND MEASURES OF SUCCESS
•Lead and develop a team of pricing and HEOR specialists; set standards, tools and operating routines for the region.
•Build pricing, reference and HEOR capability across the Middle East Access & Value community.
•Measure of success: Regional pricing approach and governance established across all markets, with full compliance to approved pricing.
•Measure of success: Pricing submissions and approvals delivered on registration timelines across Egypt, Levant and Iraq.
•Measure of success: Sustainable price realization across Gulf, Egypt and distributor markets, with international reference-price exposure actively managed.
•Measure of success: Evidence delivered on time for priority submissions; faster time from approval to patient access.
DECISION RIGHTS
•Recommends regional pricing, launch prices, sequencing and exceptions; decides within delegated governance, escalates above it.
•Sets HEOR and value-evidence priorities and approves model and dossier quality before external use.
•Owns the launch gate: no submission proceeds without the gate confirmed.
•Allocates the work of the team across markets and assets.
CAPABILITIES & QUALIFICATIONS
•Bachelor’s degree in Pharmacy, Health Economics, Economics, Finance, Life Sciences or a related field.
•Minimum 8 years of pharmaceutical or healthcare experience.
•Fluent in English; Arabic preferred.
PREFERRED
•MSc Health Economics, MPH or MBA.
•Previous experience in pricing and HEOR.
•Demonstrated experience with international reference pricing and formal pricing governance.
•Experience leading people or a specialist function.
•Direct experience with Egyptian Drug Authority (EDA) pricing rules, Gulf external reference pricing or tender pricing.
•Experience in distributor-led markets and registration-linked pricing.
CRITICAL LEADERSHIP BEHAVIORS
Enterprise Leadership
Thinks across markets and functions; makes choices for total Middle East value.
External Influence
Builds trust with payers and authorities using evidence and integrity.
Strategic Judgment
Balances patient access, affordability, price sustainability and business value.
Capability Builder
Sets standards, coaches colleagues across the region and raises functional depth.
KEY ORGANIZATIONAL RELATIONSHIPS
•Access & Value Lead — Middle East (reporting line) and the Access & Value team in Cairo and Dubai
•Country and category commercial leadership and their teams; tender, commercial excellence and partner-market teams
•Medical, Regulatory, Policy & Public Affairs, Finance, Legal, Compliance, Supply
•Regional and Global Access & Value, Pricing, HEOR and Evidence teams
OPERATING MODEL
People leader with three direct reports, all based in Cairo. Sets pricing and evidence standards for the region, applied by market access colleagues in each market. Supports Gulf markets in close partnership with Gulf-based access, payer and HEOR counterparts.
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers .
Market Access